TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection

Cell Reports

Volumn 15, Issue 5, 2016, Pages 1062-1075

  Schleicher, Ulrike ^a   Paduch, Katrin ^a   Debus, Andrea ^a   Obermeyer, Stephanie ^a   König, Till ^b,h   Kling, Jessica C ^c,i   Ribechini, Eliana ^d   Dudziak, Diana ^a,e   Mougiakakos, Dimitrios ^a,e   Murray, Peter J ^f   Ostuni, Renato ^g,j   Körner, Heinrich ^c   Bogdan, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^h NOVARTIS PHARMA AG   (Switzerland)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ARGINASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; MESSENGER RNA; NITRIC OXIDE; STAT6 PROTEIN; TUMOR NECROSIS FACTOR; 3-NITROTYROSINE; ARGINASE; BIOLOGICAL MARKER; HISTONE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; HISTONE ACETYLATION; LEISHMANIASIS; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PARASITE LOAD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN LEISHMANIASIS; SKIN ULCER; TH2 CELL; ACETYLATION; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL COUNT; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; LEISHMANIA MAJOR; METABOLISM; PATHOLOGY; T LYMPHOCYTE; UPREGULATION;

ACETYLATION; ANIMALS; ARGINASE; BIOMARKERS; CELL COUNT; DENDRITIC CELLS; HISTONES; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGES; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE PHOSPHORYLATION; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; UP-REGULATION;

EID: 84963966345     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.04.001     Document Type: Article

References (65)

1. Allenbach C., Launois P., Mueller C., Tacchini-Cottier F. An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Eur. J. Immunol. 2008, 38:720-731.
2. Allman W.R., Dey R., Liu L., Siddiqui S., Coleman A.S., Bhattacharya P., Yano M., Uslu K., Takeda K., Nakhasi H.L., Akkoyunlu M. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection. Proc. Natl. Acad. Sci. USA 2015, 112:E4094-E4103.
3. Atreya R., Neumann H., Neufert C., Waldner M.J., Billmeier U., Zopf Y., Willma M., App C., Münster T., Kessler H., et al. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nat. Med. 2014, 20:313-318.
4. Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 2015, 36:161-178.
5. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992, 360:258-261.
6. Colegio O.R., Chu N.Q., Szabo A.L., Chu T., Rhebergen A.M., Jairam V., Cyrus N., Brokowski C.E., Eisenbarth S.C., Phillips G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 2014, 513:559-563.
7. Colotti G., Ilari A. Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids 2011, 40:269-285.
8. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 2010, 107:21931-21936.
9. ω-hydroxy-nor-L-arginine: a high-affinity inhibitor of arginase well adapted to bind to its manganese cluster. J. Am. Chem. Soc. 1997, 119:4086-4087.
10. De Muylder G., Daulouède S., Lecordier L., Uzureau P., Morias Y., Van Den Abbeele J., Caljon G., Hérin M., Holzmuller P., Semballa S., et al. A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity. PLoS Pathog. 2013, 9:e1003731.
11. De Trez C., Magez S., Akira S., Ryffel B., Carlier Y., Mraille E. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection of C57BL/6 resistant mice. PLoS Pathogens 2009, 5:e1000494.
12. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998, 8:77-87.
13. Duque-Correa M.A., Kühl A.A., Rodriguez P.C., Zedler U., Schommer-Leitner S., Rao M., Weiner J., Hurwitz R., Qualls J.E., Kosmiadi G.A., et al. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas. Proc. Natl. Acad. Sci. USA 2014, 111:E4024-E4032.
14. El-Gayar S., Thüring-Nahler H., Pfeilschifter J., Röllinghoff M., Bogdan C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J. Immunol. 2003, 171:4561-4568.
15. El Kasmi K.C., Qualls J.E., PesFce J.T., Smith A.M., Thompson R.W., Henao-Tamayo M., Basaraba R.J., König T., Schleicher U., Koo M.S., et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 2008, 9:1399-1406.
16. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., Bloom B.R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2:561-572.
17. Fromm P.D., Kling J., Mack M., Sedgwick J.D., Körner H. Loss of TNF signaling facilitates the development of a novel Ly-6C(low) macrophage population permissive for Leishmania major infection. J. Immunol. 2012, 188:6258-6266.
18. Gao X., Xu X., Belmadani S., Park Y., Tang Z., Feldman A.M., Chilian W.M., Zhang C. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1269-1275.
19. Garber M., Yosef N., Goren A., Raychowdhury R., Thielke A., Guttman M., Robinson J., Minie B., Chevrier N., Itzhaki Z., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
20. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128. Immunological Genome Consortium.
21. Ginhoux F., Schultze J.L., Murray P.J., Ochando J., Biswas S.K. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat. Immunol. 2015, 17:34-40.
22. Green S.J., Crawford R.M., Hockmeyer J.T., Meltzer M.S., Nacy C.A. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α. J. Immunol. 1990, 145:4290-4297.
23. Grivennikov S.I., Tumanov A.V., Liepinsh D.J., Kruglov A.A., Marakusha B.I., Shakhov A.N., Murakami T., Drutskaya L.N., Förster I., Clausen B.E., et al. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 2005, 22:93-104.
24. Huang S.C., Everts B., Ivanova Y., O'Sullivan D., Nascimento M., Smith A.M., Beatty W., Love-Gregory L., Lam W.Y., O'Neill C.M., et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014, 15:846-855.
25. Iniesta V., Carcelén J., Molano I., Peixoto P.M.V., Redondo E., Parra P., Mangas M., Monroy I., Campo M.L., Nieto C.G., Corraliza I. Arginase I induction during Leishmania major infection mediates the development of disease. Infect. Immun. 2005, 73:6085-6090.
26. Iyer R.K., Yoo P.K., Kern R.M., Rozengurt N., Tsoa R., O'Brien W.E., Yu H., Grody W.W., Cederbaum S.D. Mouse model for human arginase deficiency. Mol. Cell. Biol. 2002, 22:4491-4498.
27. Kirchner H., Holden H.T., Herberman Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J. Immunol. 1975, 115:1212-1216.
28. Körner H., McMorran B., Schlüter D., Fromm P. The role of TNF in parasitic diseases: still more questions than answers. Int. J. Parasitol. 2010, 40:879-888.
29. Kratochvill F., Neale G., Haverkamp J.M., Van de Velde L.A., Smith A.M., Kawauchi D., McEvoy J., Roussel M.F., Dyer M.A., Qualls J.E., Murray P.J. TNF counterbalances the emergence of M2 tumor macrophages. Cell Rep. 2015, 12:1902-1914.
30. Kroner A., Greenhalgh A.D., Zarruk J.G., Passos Dos Santos R., Gaestel M., David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
31. Kropf P., Fuentes J.M., Fähnrich E., Arpa L., Herath S., Weber V., Soler G., Celada A., Modolell M., Müller I. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005, 19:1000-1002.
32. Lavin Y., Winter D., Blecher-Gonen R., David E., Keren-Shaul H., Merad M., Jung S., Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 2014, 159:1312-1326.
33. Liew F.Y., Li Y., Millott S. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 1990, 145:4306-4310.
34. Louis C.A., Reichner J.S., Henry W.L., Mastrofrancesco B., Gotoh T., Mori M., Albina J.E. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am. J. Physiol. 1998, 274:R775-R782.
35. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., et al. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 1997, 94:8093-8098.
36. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164:6166-6173.
37. Morris S.M. Recent advances in arginine metabolism: roles and regulation of the arginases. Br. J. Pharmacol. 2009, 157:922-930.
38. Munder M., Choi B.S., Rogers M., Kropf P. L-arginine deprivation impairs Leishmania major-specific T-cell responses. Eur. J. Immunol. 2009, 39:2161-2172.
39. Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., Gordon S., Hamilton J.A., Ivashkiv L.B., Lawrence T., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41:14-20.
40. Nashleanas M., Kanaly S., Scott P. Control of Leishmania major infection in mice lacking TNF receptors. J. Immunol. 1998, 160:5506-5513.
41. Novosad S.A., Winthrop K.L. Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae. Clin. Infect. Dis. 2014, 58:1587-1598.
42. Olekhnovitch R., Ryffel B., Müller A.J., Bousso P. Collective nitric oxide production provides tissue-wide immunity during Leishmania infection. J. Clin. Invest. 2014, 124:1711-1722.
43. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., Curina A., Prosperini E., Ghisletti S., Natoli G. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
44. Pauleau A.L., Rutschman R., Lang R., Pernis A., Watowich S.S., Murray P.J. Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 2004, 172:7565-7573.
45. Pesce J.T., Ramalingam T.R., Mentink-Kane M.M., Wilson M.S., El Kasmi K.C., Smith A.M., Thompson R.W., Cheever A.W., Murray P.J., Wynn T.A. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009, 5:e1000371.
46. Pfeffer K., Matsuyama T., Kündig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Krönke M., Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467.
47. Prajeeth C.K., Haeberlein S., Sebald H., Schleicher U., Bogdan C. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity. Infect. Immun. 2011, 79:2699-2708.
48. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
49. Reguera R.M., Balaña-Fouce R., Showalter M., Hickerson S., Beverley S.M. Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice. Mol. Biochem. Parasitol. 2009, 165:48-56.
50. Riminton S.D., Körner H., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 1998, 187:1517-1528.
51. Rutschman R., Lang R., Hesse M., Ihle J.N., Wynn T.A., Murray P.J. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 2001, 166:2173-2177.
52. Sade-Feldman M., Kanterman J., Ish-Shalom E., Elnekave M., Horwitz E., Baniyash M. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013, 38:541-554.
53. Serrat N., Pereira-Lopes S., Comalada M., Lloberas J., Celada A. Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages. Eur. J. Immunol. 2012, 42:3028-3037.
54. Sheldon K.E., Shandilya H., Kepka-Lenhart D., Poljakovic M., Ghosh A., Morris S.M. Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter. J. Immunol. 2013, 191:2290-2298.
55. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287-292.
56. Tamoutounour S., Guilliams M., Montanana Sanchis F., Liu H., Terhorst D., Malosse C., Pollet E., Ardouin L., Luche H., Sanchez C., et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013, 39:925-938.
57. Titus R.G., Sherry B., Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 1989, 170:2097-2104.
58. Tsunawaki S., Nathan C.F. Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium. J. Exp. Med. 1986, 164:1319-1331.
59. Tung Chen Y., Perales C., Lacruz J., Senent L., Salavert M. Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review. Int. J. Rheum. Dis. 2014, 17:822-824.
60. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992, 10:411-452.
61. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., Wagner R.A., Greaves D.R., Murray P.J., Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4:13-24.
62. Wilhelm P., Ritter U., Labbow S., Donhauser N., Röllinghoff M., Bogdan C., Körner H. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 2001, 166:4012-4019.
63. Witte M.B., Barbul A., Schick M.A., Vogt N., Becker H.D. Upregulation of arginase expression in wound-derived fibroblasts. J. Surg. Res. 2002, 105:35-42.
64. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
65. Yazdanpanah B., Wiegmann K., Tchikov V., Krut O., Pongratz C., Schramm M., Kleinridders A., Wunderlich T., Kashkar H., Utermöhlen O., et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 2009, 460:1159-1163.